A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport

Not Applicable

Completed

• Conditions: Medication Adherence
• Interventions: Behavioral: Patient participation; Other: Clinician barrier reports

• Registration Number: NCT05150028
• Lead Sponsor: Roswell Park Cancer Institute

Brief Summary

To develop a cancer center level practice intervention to promote treatment adherence and reduce outcome disparities in pediatric cancer survivors

Detailed Description

To conduct a pilot study to assess the feasibility and acceptability of the Social Determinants of Adherence intervention

Study Timeline

• Study First Submitted: 2021-11-24
• Study First Submitted QC: 2021-12-06
• Study First Posted: 2021-12-08
• Study Start: 2023-04-11
• Primary Completion: 2023-06-06
• Study Completion: 2024-06-06
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-16
• Last Update Posted: 2024-07-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

Parents/caregivers of pediatric patients must meet the following criteria to be eligible:

• Parents/guardians of child that has been diagnosed with any cancer.
• Parents/guardians of child with any cancer between age 0 and 18.
• Parents/guardians of child on home-based oral anti-cancer therapy or supportive care therapy.
• The clinician for the family agrees to participate in the study.

Exclusion Criteria

• Participants will be excluded from this study if unwilling or unable to complete the assessment in English

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention - Pediatric parent/caregiver	Patient participation	Questionnaires along with educational videos
Clinicians	Clinician barrier reports	Will complete pre and post survey about medication education practices

Primary Outcome Measures

Name	Time	Method
Retention rates	Up to 8 weeks	Feasibility of intervention as assessed by retention rates

Secondary Outcome Measures

Name	Time	Method
Feasibility of universal SDOA screening	up to 8 weeks	Will be assessed by results of SDOA questionnaire an 8 item questionnaire rated on a 5-point Likert scale (0-I never experienced this ; 5 - I experience this quite a lot)
Provider satisfaction with barrier reports	up to 8 weeks	REDCap analytics will track the rate of opened barrier reports

Trial Locations

Locations (1)

Roswell Park Cancer Institute; 🇺🇸 Buffalo, New York, United States